Hans Keirstead, Ph.D
Hans Keirstead, Ph.D

Chairman of Immunis Inc

Dr. Keirstead is an internationally known stem cell expert and serial
entrepreneur that led the development of a treatment that restored
movement and sensory function to people with quadriplegic spinal
cord injury, and a treatment for cancer that has saved the lives of
people with melanoma, brain cancer and ovarian cancer. He has also
led therapy development for immune disorders, motor neuron
diseases and retinal diseases, as well as a vaccine for COVID-19. He
has founded 4 successful biotechnology companies, each returning
significant value to investors and treatments to patients. Every one of
his prior companies has sold to large or mid-sized pharmaceutical
companies for 2.5X-9.5X returns to investors, after return of
investment capital. Dr. Keirstead holds Board positions in several
prominent biotechnology companies.
Previously, he was a Professor at the University of California, Irvine where he founded and directed
and raised the money to build the $77 million Sue and Bill Gross Stem Cell Research Center. As a Full
Professor of Anatomy and Neurobiology, he was awarded over $16 million in grants during his 15-
year tenure. He has mentored over 100 students, published over 100 manuscripts, and granted over
20 patents. He was awarded the Distinguished Award for Research, the UCI Academic Senate’s
highest honor, as well as the UCI Innovation Award for innovative research leading to corporate and
clinical development. He was awarded the National Institutes of Health’s Solowey Award for the most
promising scientist of the year. He was awarded the Touching One Billion People Award by
Singularity University. He was a founding advisor of the California Stem Cell Initiative that resulted in
a $3 billion stem cell fund (CIRM). He has been a long-time advisor to several governments on
biomedical policy.
Dr. Keirstead has been a notable figure in the field of regenerative medicine for over three decades.
His work in spinal cord injury earned him the distinction of being one of 100 top scientists of the
year in Discover Magazine. He was featured on 60 minutes in a full segment covering his treatment
for spinal cord injury. Dr. Keirstead also appeared in Newsweek, Inc. Magazine, WIRED, Esquire, The
NY Times, TIME Magazine, Men’s Vogue, Science and The American Spectator, amongst other
national publications. He has given dozens of keynote addresses, was a TEDx speaker, was recently
honored as one of 7 thought leaders in Canada at the Seven Wonderer’s event by Beakerhead and
was recently awarded the Top 20 Canadians Award by the Consul General of Canada.
Dr. Keirstead received his Ph.D. in neuroscience from the University of British Columbia, Canada for
which he received the Cameron Award for the outstanding Ph.D. thesis in the country. He conducted
Post-Doctoral studies at the University of Cambridge. He received the distinct honor of election as
Senate Member of the University of Cambridge and Fellow of the Governing Body of Downing
College, and was the youngest member to have been elected to those positions.

Organized by